Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology

Area of Science:

• Gastroenterology
• Inflammatory Bowel Disease (IBD) Research
• Surgical Gastroenterology

Background:

• Chronic pouchitis treatment lacks high-quality studies, posing a challenge for clinicians.
• Expert guidance is needed for appropriate medical and surgical interventions in chronic pouchitis.

Purpose of the Study:

• To provide clinical guidance on the appropriateness of medical and surgical treatments for chronic pouchitis.
• To evaluate treatment options based on specific patient variables and expert consensus.

Main Methods:

• Utilized the RAND/UCLA appropriateness method with international IBD expert panelists.
• Assessed 16 scenarios for medical treatments and 8 for permanent ileostomy based on symptoms, antibiotic response, prepouch ileitis, and Crohn's disease (CD)-like complications.
• Panelists rated treatment appropriateness on a 1-9 scale.

Main Results:

• Chronic antibiotics appropriate only for asymptomatic, antibiotic-dependent patients without CD-like complications.
• Ileal-release budesonide appropriate in specific scenarios, particularly with prepouch ileitis but no CD-like complications.
• Probiotics deemed inappropriate or uncertain; biologic therapy appropriate in most cases, except when complications are absent.
• Permanent ileostomy appropriate for most medically refractory patients, except asymptomatic ones without complications.

Conclusions:

• Chronic antibiotics and probiotics are inappropriate with prepouch ileitis or CD-like complications.
• Biologics are appropriate for nearly all patients, barring asymptomatic cases without complications.
• Permanent ileostomy is a suitable option for patients refractory to medical treatments.